Phase II trial of seasonal influenza virus vaccine (NasoVAX)
Phase of Trial: Phase II
Latest Information Update: 04 May 2017
At a glance
- Drugs Influenza virus vaccine (NasoVAX) (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 04 May 2017 According to an Altimmune media release, this study is expected to commence during 3Q of 2017 with initial data expected in 1Q of 2018.
- 19 Jan 2017 According to a PharmAthene media release, this study is expected to commence during mid-2017 with initial data expected in the fourth quarter of 2017.
- 24 Feb 2015 New trial record